39
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Relationship Between Family History and Quality of Life in Patients with Psoriasis: A Cross-Sectional Study from China

, , , , , & show all
Pages 891-900 | Received 03 Dec 2023, Accepted 13 Apr 2024, Published online: 22 Apr 2024

References

  • Griffiths CEM, Armstrong AW, Gudjonsson JE, et al. Psoriasis. Lancet. 2021;397(10281):1301–1315. doi:10.1016/S0140-6736(20)32549-6
  • Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(2):205–212. doi:10.1111/jdv.13854
  • Solmaz D, Bakirci S, Kimyon G, et al. Impact of having family history of psoriasis or psoriatic arthritis on psoriatic disease. Arthr Care Res. 2020;72(1):63–68. doi:10.1002/acr.23836
  • Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945–1960. doi:10.1001/jama.2020.4006
  • Long CC, Finlay AY. The finger-tip unit--A new practical measure. Clin Exp Dermatol. 1991;16(6):444–447. doi:10.1111/j.1365-2230.1991.tb01232.x
  • Fredriksson T, Pettersson U. Severe psoriasis--oral therapy with a new retinoid. Dermatologica. 1978;157(4):238–244. doi:10.1159/000250839
  • Feldman SR, Krueger GG. Psoriasis assessment tools in clinical trials. Ann Rheumatic Dis. 2005;64(Suppl 2):ii65–68; discussion ii69–73. doi:10.1136/ard.2004.031237
  • Mease PJ, Palmer JB, Hur P, et al. Utilization of the validated psoriasis epidemiology screening tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross-sectional analysis from the US-based corrona psoriasis registry. J Eur Acad Dermatol Venereol. 2019;33(5):886–892. doi:10.1111/jdv.15443
  • Mease PJ. Measures of psoriatic arthritis: tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI). Arthr Care Res. 2011;63(Suppl 11):S64–85.
  • Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--A simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–216. doi:10.1111/j.1365-2230.1994.tb01167.x
  • Ohata C, Anezaki H, Kaneko S, et al. Clinical characteristics of patients with psoriasis with family history: a multicenter observational study. J Dermatol. 2023;50(6):746–752. doi:10.1111/1346-8138.16733
  • Liu H, Lu C, Yang F, et al. Associations between family history of psoriatic disease and clinical characteristics on patients with psoriatic arthritis: a nationwide study from the Chinese Registry of Psoriatic Arthritis (CREPAR II). Clin Exper Rheumatol. 2023;41(9):1901–1907. doi:10.55563/clinexprheumatol/gbg5i5
  • López-Estebaranz JL, Sánchez-Carazo JL, Sulleiro S. Effect of a family history of psoriasis and age on comorbidities and quality of life in patients with moderate to severe psoriasis: results from the Arizona study. J Dermatol. 2016;43(4):395–401. doi:10.1111/1346-8138.13157
  • Basra MK, Sue-Ho R, Finlay AY. The family dermatology life quality index: measuring the secondary impact of skin disease. Br J Dermatol. 2007;156(3):528–538. doi:10.1111/j.1365-2133.2006.07617.x
  • Martínez-García E, Arias-Santiago S, Valenzuela-Salas I, et al. Quality of life in persons living with psoriasis patients. J Am Acad Dermatol. 2014;71(2):302–307. doi:10.1016/j.jaad.2014.03.039
  • Hawro T, Zalewska A, Hawro M, et al. Impact of psoriasis severity on family income and quality of life. J Eur Acad Dermatol Venereol. 2015;29(3):438–443. doi:10.1111/jdv.12572
  • Qing M, Liu P, Zhu W, et al. Analysis for 208 children with psoriasis vulgaris. Zhong Nan da Xue Xue Bao Yi Xue Ban. 2020;45(7):804–811. doi:10.11817/j.issn.1672-7347.2020.190129
  • Di Lernia V, Ficarelli E, Lallas A, et al. Familial aggregation of moderate to severe plaque psoriasis. Clin Exp Dermatol. 2014;39(7):801–805. doi:10.1111/ced.12401
  • Chen Y, Wei L, Song Y, et al. Life quality among psoriasis patients based on dermatology life quality index evaluation and its association with psoriasis severity in China: a cross-sectional study. Ann Med. 2023;55(1):2231847. doi:10.1080/07853890.2023.2231847
  • Herédi E, Rencz F, Balogh O, et al. Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary. Eur J Health Econ. 2014;15(Suppl 1):S111–119. doi:10.1007/s10198-014-0600-x
  • Wade AG, Crawford GM, Young D, et al. Severity and management of psoriasis within primary care. BMC Fam Pract. 2016;17(1):145. doi:10.1186/s12875-016-0544-6
  • Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheumatic Dis. 2005;64(Suppl 2):ii14–17. doi:10.1136/ard.2004.032482
  • Yang J, Hu K, Li X, et al. Psoriatic foot involvement is the most significant contributor to the inconsistency between PASI and DLQI: a Retrospective Study from China. Clin Cosmet Invest Dermatol. 2023;16:443–451. doi:10.2147/CCID.S396997
  • Loft ND, Egeberg A, Rasmussen MK, et al. Patient-reported outcomes during treatment in patients with moderate-to-severe psoriasis: a Danish nationwide study. Acta Dermato Venereologica. 2019;99(13):1224–1230. doi:10.2340/00015555-3331
  • Xia P, Chen J, Yang M, et al. Clinical features of Chinese psoriatic patients for early referral of arthritis using psoriasis epidemiology screening tool: a cross-sectional analysis from the registry database of Chinese psoriasis standardized diagnosis and treatment center. Chinese Med J. 2023;136(16):1999–2001. doi:10.1097/CM9.0000000000002748
  • Ogdie A, Harrison RW, McLean RR, et al. Prospective cohort study of psoriatic arthritis risk in patients with psoriasis in a real-world psoriasis registry. J Am Acad Dermatol. 2022;87(6):1303–1311. doi:10.1016/j.jaad.2022.07.060
  • Rahman P, Schentag CT, Beaton M, et al. Comparison of clinical and immunogenetic features in familial versus sporadic psoriatic arthritis. Clin Exper Rheumatol. 2000;18(1):7–12.
  • Gamonal SBL, Gamonal ACC, Brandão MAF, et al. Prevalence of psoriatic arthritis among patients with plaque psoriasis: a Brazilian retrospective study. São Paulo Med J. 2021;139(5):476–480. doi:10.1590/1516-3180.2020.0629.16032021
  • Armstrong AW, Bohannan B, Mburu S, et al. Patient Perspectives on Psoriatic Disease Burden: Results from the Global Psoriasis and Beyond Survey. Dermatology. 2023. Vol. 239(4):621–634.
  • Rosen CF, Mussani F, Chandran V, et al. Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone. Rheumatology. 2012;51(3):571–576. doi:10.1093/rheumatology/ker365
  • Dalal DS, Lin YC, Brennan DM, et al. Quantifying harmful effects of psoriatic diseases on quality of life: cardio-metabolic outcomes in psoriatic arthritis study (COMPASS). Semin Arthritis Rheumatism. 2015;44(6):641–645. doi:10.1016/j.semarthrit.2015.01.003
  • Naldi L, Parazzini F, Brevi A, et al. Family history, smoking habits, alcohol consumption and risk of psoriasis. Br J Dermatol. 1992;127(3):212–217. doi:10.1111/j.1365-2133.1992.tb00116.x
  • Lim DS, Bewley A, Oon HH. Psychological Profile of Patients with Psoriasis. Ann Acad Med Singapore. 2018;47(12):516–522. doi:10.47102/annals-acadmedsg.V47N12p516